MedPath

*REGISTRY - an observational study of the European Huntington's Disease Network (EHDN)*

Completed
Conditions
10028037
Huntington's disease
Registration Number
NL-OMON38177
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
800
Inclusion Criteria

.Individuals with clinical features of HD with a confirmatory family history of HD or with DNA testing results demonstrating the presence of the HD mutation (i.e. a CAG repeat expansion within the HD gene >35 on larger allele)
•Individuals without clinical features of HD with DNA testing result demonstrating presence of the HD mutation (i.e. CAG repeat expansion within the HD gene >35 on larger allele)
•First-degree relatives (i.e. parents, siblings, or children) of individuals with HD
•Second-degree relatives (i.e. grandparents and grandchildren) of participating individuals with HD
•Family members of participating individuals from category 1 or 2 who are know not to carry the HD mutation (e.g., spouses)

Exclusion Criteria

• Subjects who are unable to understand the study protocol or unable to give informed consent, and have no legal representative.
•Participants with choreic movement disorder other than HD.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>There is no fixed end of study as 'Registry' will take place during visits at<br /><br>the out-patient clinic of the department of Neurology or nursing home. The<br /><br>study is imbedded in the network that provides a platform for communication and<br /><br>exchange of views on HD and a basis for research. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>n.v.t.</p><br>
© Copyright 2025. All Rights Reserved by MedPath